Pharma BD Deal Intelligence

Merck & Co. Inc. / Aton Pharma Inc.

2004 · Acquisition/Merger · Complete

April 2004; SAHA/vorinostat HDAC inhibitor; led to Zolinza FDA approval Oct 2006 for CTCL; deal value undisclosed

Key facts

• Announced Apr 01, 2004
• Deal type Acquisition/Merger

← Browse all deals  ·  How we score deals